A D S Diagnostics Ltd (ADSDIAG) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by A D S Diagnostics Ltd on NSE and BSE, with an AI summary of each filing.
A D S Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve Notice is hereby given pursuant ....
Intimation · 12 Nov 2026, 5:30 am
ADS Diagnostic Schedules Board Meeting for Q2 FY27 Financial Results ADS Diagnostic Limited has informed the BSE that a meeting of its Board of Directors is scheduled for Thursday, 12th Nov'26, at its registered office. The board will primarily consider and approve the unaudited financial results of the company for the quarter ended 30th Sep'26, alongside other general business matters.
The voting Results as format prescribed under Regulation 44(3) of SEBI(LODR) Regulations, 2015 along with Scrutiniser Report on remote e- voting, are attached
Annual General Meeting · 01 Oct 2026, 5:03 pm
ADS Diagnostic Shareholders Approve All Resolutions at 41st AGM ADS Diagnostic Limited announced that shareholders approved all four ordinary and five special resolutions at its 41st AGM held on 29th Sep'26 via remote e-voting and AGM e-voting. Passed ordinary resolutions include the adoption of FY26 financial statements (98.78% in favor), re-appointment of director Dr. Radhika Sehgal (96.91%), FY26 equity dividend declaration (99.51%), and statutory auditor ratification for M/s. V. N. Purohit & Co. (95.77%). Special resolutions approved director re-appointments, regularisation of Independent Director Abhay Singh, and appointment of M/s. Nitesh Singh & Associates as secretarial auditor for FY27–FY31.
List of Proceedings of Annual General Meeting of the Company held today i.e. September 29, 2026 is attached.
Annual General Meeting · 29 Sept 2026, 9:32 pm
Pursuant to regulation 42 of SEBI please find enclosed the date of record date for determining the record date for payment of divided to shareholders and date of book closure and determining ....
Annual General Meeting · 22 Sept 2026, 6:55 pm
Pursuant to Regulation 42 of SBEI(LODR), 2015 and in continuation of our disclosure of even reference dated 04th September, 2026 regarding the 41st AGM, we hereby give advance notice that: 1. ....
Annual General Meeting · 21 Sept 2026, 7:30 pm
NOTICE IS HEREBY GIVEN that the 41st Annual General Meeting of the Members of ADS Diagnostic Limited will be held on Tuesday, the 29th September, 2026, at 11:30 A.M. Through Video Conferencing ....
Others (Uncategorized) · 04 Sept 2026, 8:13 pm
Pursuant to the provisions of Regulation 33 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''SEBI LODR''), we wish to inform ....
Outcome · 13 Aug 2026, 6:46 pm
A D S Diagnostics Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR Lakhs) ■ Revenue: 352 (-20.1% YoY | -13.0% QoQ) ■ EBITDA: 15.6 (-55.2% YoY | -45.8% QoQ) ■ EBITDA Margin (%): 4.4 (-347 bps YoY | -269 bps QoQ) ■ PAT: 3.2 (-78.2% YoY | -72.3% QoQ) ■ EPS (INR): 0.15 (-77.6% YoY | -71.7% QoQ)
A D S Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve The meeting of the Board ....
Intimation · 13 Aug 2026, 5:30 am
ADS Diagnostic Board Meeting to Approve Q1FY27 Financial Results ADS Diagnostic Limited has scheduled a Board of Directors meeting for 13th Aug'26. The primary agenda is to consider and approve the audited financial results for the quarter ended 30th Jun'26. The meeting will be held at the company's registered office or via Zoom. Any other business items may also be discussed with the Chairman's permission.
Pursuant to the provisions of Regulation 33 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''SEBI LODR''), we wish to inform ....
Outcome · 29 May 2026, 7:11 pm
A D S Diagnostics Ltd - Financial Result for the Quarter ended 31st Mar'26 (Standalone, INR Lacs) ■ Revenue: 404 (+19.7% YoY | -26.0% QoQ) ■ EBITDA: 28.8 (+35.2% YoY | -36.7% QoQ) ■ EBITDA Margin (%): 7.1 (+82 bps YoY | -120 bps QoQ) ■ PAT: 11.6 (+63.7% YoY | -41.2% QoQ) ■ EPS (INR): 0.53 (+65.6% YoY | -41.1% QoQ)
A D S Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Board Meeting of ADS Diagnostic ....
Intimation · 29 May 2026, 5:30 am
ADS Diagnostic Board Meeting to Approve Q4FY26 Financials ADS Diagnostic Limited has scheduled a Board of Directors meeting on 29th May'26. The primary agenda is to consider and approve the audited financial results for the quarter ended 31st Mar'26. The meeting will be held at the company's registered office. Other business items may also be discussed with the permission of the Chairman.
Pursuant to the provisions of Regulation 33 and other applicable provisions of SEBI we wish to inform you that the Board of Directors (the ''Board'') of ADS Diagnostic Limited (''the Company'') ....
Outcome · 13 Feb 2026, 8:56 pm
ADS Diagnostic Q3 FY26 Net Profit Rises 3.2% YoY ADS Diagnostic Limited reported a net profit of ₹19.81 lacs for Q3 FY26, a 3.2% YoY increase from ₹19.19 lacs. Revenue from operations grew 110.4% YoY to ₹542.89 lacs. However, on a QoQ basis, revenue declined 63.0% and net profit fell 67.4% from ₹60.83 lacs in Q2 FY26. Total expenses increased 121.2% YoY to ₹520.12 lacs, primarily driven by a significant rise in the cost of materials consumed. Basic EPS for the quarter was ₹0.90, compared to ₹0.88 YoY and ₹2.77 QoQ.
A D S Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve Board meeting of ads diagnostic ....
Intimation · 13 Feb 2026, 5:30 am
ADS Diagnostic Board Meeting to Approve Q3FY26 Results ADS Diagnostic Ltd. has scheduled a Board of Directors meeting on 13th Feb'26 to consider and approve the company's Unaudited Financial Results for the quarter ended 31st Dec'25. This meeting is pursuant to Regulation 29 of SEBI (LODR) Regulations, 2015. Any other business may also be considered with the Chairman's permission. The outcome will provide key insights into the company's Q3 performance.
Pursuant to the provisions of Regulation 33 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''SEBI LODR''), we wish to inform ....
Outcome · 12 Nov 2025, 9:54 pm
A D S Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve Notice is hereby given pursuant ....
Intimation · 12 Nov 2025, 5:30 am
proceedings of 40th annual general meeting of ads diagnostic limited
Annual General Meeting · 29 Sept 2025, 10:12 pm
NOTICE IS HEREBY GIVEN that the 40th Annual General Meeting of the Members of ADS Diagnostic Limited will be held on Monday, the 29th September, 2025, at 11:30 A.M. Through Video Conferencing ....
Others (Uncategorized) · 30 Aug 2025, 10:37 pm
Pursuant to the provisions of Regulation 33 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''SEBI LODR''), we wish to inform ....
Outcome · 12 Aug 2025, 9:08 pm
A D S Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve Board meeting of ADS Diagnostic ....
Intimation · 12 Aug 2025, 5:30 am
Pursuant to the provisions of Regulation 33 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''SEBI LODR''), we wish to inform ....
Revision of outcome · 30 May 2025, 10:54 pm
Pursuant to the provisions of Regulation 33 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''SEBI LODR''), we wish to inform ....
Outcome · 30 May 2025, 7:59 pm